"Amphibian Venoms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.
| Descriptor ID |
D000664
|
| MeSH Number(s) |
D20.888.033 D23.946.833.033
|
| Concept/Terms |
Amphibian Venoms- Amphibian Venoms
- Venoms, Amphibian
- Amphibian Venom
- Venom, Amphibian
Frog Venoms- Frog Venoms
- Venoms, Frog
- Frog Venom
- Venom, Frog
Toad Venom- Toad Venom
- Venom, Toad
- Toad Venoms
- Venoms, Toad
|
Below are MeSH descriptors whose meaning is more general than "Amphibian Venoms".
Below are MeSH descriptors whose meaning is more specific than "Amphibian Venoms".
This graph shows the total number of publications written about "Amphibian Venoms" by people in this website by year, and whether "Amphibian Venoms" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Amphibian Venoms" by people in Profiles.
-
Huachansu mediates cell death in non-Hodgkin's lymphoma by induction of caspase-3 and inhibition of MAP kinase. Int J Oncol. 2015 Aug; 47(2):592-600.
-
Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. Br J Cancer. 2012 Jul 24; 107(3):411-6.
-
Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells. Anticancer Res. 2011 Jun; 31(6):2141-8.
-
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 2009 Nov 15; 115(22):5309-18.